triangle

About Us

Serimmune is an immune intelligence company that provides a holistic view of immunity to identify environmental factors in disease and health. The unique information we provide fuels development of new diagnostics, vaccines, and therapeutics.

Founded in 2014, and backed by investors including Illumina Ventures, LabCorp, and Merck, Serimmune is developing new approaches for preventing, diagnosing, and treating a range of diseases.

triangle

Leadership

Patrick
Daugherty, PH.D.

Founder, Chief Executive Officer,
and Chief Science Officer

JOHN
SHON, M.D., M.S.

Chief Technology Officer

JAYMIE R.
SAWYER, PH.D.

Vice President, Product
Development

STEVE
KUJAWA, MBA

Vice President, Business
Development

Board of Directors

NICK
NACLERIO, PH.D.

Founding Partner, Illumina Ventures

TOM
WILLIS, PH.D.

Partner, Illumina Ventures

KRISTIN
LOOMIS, MBA

President & Executive Director,
HHV-6 Foundation

PATRICK
DAUGHERTY, PH.D.

Founder, CEO & CSO, Serimmune

triangles

Investors